Mice models are indispensable tools in research activities with their capability to elucidate human disease processes, due to striking similarities between the anatomy, physiology, and genetics of humans and mice. These advantages promote scientific discovery, understanding of the functions of individual genes, mechanisms of different diseases, and the effectiveness and toxicities of various drug molecules. Mice models are the most popularly used animal models due to their small size, short generation time, accelerated lifespan, low cost, and requirement of less space. These factors help in accelerating the research and development of drug therapies.

Ongoing innovations in mice models, personalized medicine fuelling the demand for personalized humanized mice models, continuous support in the form of investments and grants, and increase in R&D activities of pharmaceutical industries are some of the factors that are expected to drive the growth of the global mice model market in the coming years.

Market players are continuously focusing on innovations in mice models for research on various human diseases. Growing innovations and advances in mice models are providing increased options to researchers to conduct research activities in particular diseases, which is a major factor driving market growth.

On the other hand, factors like advancements in genetic techniques for the development of genetically modified rats have led to the increased usage of rat models, thereby restraining the mice model market to some extent. In addition, advances in zebrafish model development, increased benefits from cryopreservation, regulations & laws for the ethical use of animals, and alternative methods to animal testing are some factors expected to restrain the growth of the market. Moreover, the continuous need for improved mice models is posing as a major challenge for the global mice model market.

In 2015, the inbred mice are estimated to account for the largest share of the global mice model market, by type while   genetically engineered mice models are expected to be the fastest-growing market segment, owing to high investments in the development of new and innovative knockout models that also increases the application areas for the models.

In 2015, North America is expected to account for the largest share of the global mice model market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).North America’s large share is attributed to the revised funding plans by NIH to enhance the reproducibility of results, rising demands for monoclonal antibody production, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada.

The major players in the market are focusing on various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansion, new product launches, funds/grants, licensing, patents, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the models and services offered by top playersin the mice model market. The report analyzes the mice model market, by type, technology, disease, service, and mice care products.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the mice model market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for mice models & services across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the mice model market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and  distribution networks of the leading players in the mice model market

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Industry Insights
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Global Mice Model Market
4.2 Geographic Analysis: Mice Care Products Market, By Type
4.3 Market, By Technology (2015 vs 2020)

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Ongoing Innovations in Mice Model
5.3.1.1.1 Mice Model for Immune Diseases
5.3.1.1.2 Mice Model for Cancer
5.3.1.1.3 Mice Model for Rare Diseases
5.3.1.2 Personalized Medicine to Fuel the Demand for Personalized Humanized Mice Model
5.3.1.3 Continuous Support in the Form of Grants and Investments
5.3.1.4 Increase in R&D Activities of Pharmaceutical Industries
5.3.1.5 Increasing Focus of Associations on the Development of Embryonic Stem (ES) Cells as Well as Knockout and Mutant Mice
5.3.1.5.1 International Mouse Phenotyping Consortium (IMPC)
5.3.1.5.2 International Knockout Mouse Consortium (IKMC)
5.3.2 Restraints
5.3.2.1 Increased Usage of Rat Models
5.3.2.2 Advances in Zebrafish Model Development
5.3.2.3 Increased Benefits From Cryopreservation
5.3.2.4 Regulations and Laws for Ethical Use of Animals in Research
5.3.2.4.1 The Animal Welfare Act (Awa)
5.3.2.4.2 Public Health Service Policy (PHS)On Humane Care and Use of Laboratory Animals
5.3.2.5 Alternative Methods to Animal Testing
5.3.3 Opportunities
5.3.3.1 Rising Demand of Humanized Mice Model
5.3.3.2 Increase in Monoclonal Antibody Production
5.3.4 Challenge
5.3.4.1 Need for Improved Mice Model

6 Mice Model Market, By Type
6.1 Introduction
6.2 Inbred Mice
6.3 Outbred Mice
6.4 Genetically Engineered (Knockout & Knockin) Mice
6.5 Hybrid/Congenic Mice
6.6 Conditioned/Surgically Modified Mice
6.7 Spontaneous Mutant Mice

7 Mice Model Market, By Technology
7.1 Introduction
7.2 Microinjection
7.3 Embryonic Stem Cell Injection
7.4 Nuclear Transferase
7.5 Other Technologies
7.5.1 Genetically Modified Sperm-Mediated Gene Transfer
7.5.2 Virus/Vector-Mediated Gene Transfer
7.5.3 Liposome-Mediated Dna and Electroporation of Dna
7.5.4 Biolistics
7.5.5 Crispr/Cas9, Talens, and Zfns

8 Mice Model Market, By Service
8.1 Introduction
8.2 Breeding Services
8.3 Cryopreservation Services
8.4 Quarantine Services
8.5 Rederivation Services
8.6 Model In-Licensing Services
8.7 Genetic Testing Services
8.8 Other Services

9 Mice Model Market, By Disease
9.1 Introduction
9.2 Oncology Mice Model
9.2.1 Continuous Grants/Funds to Support Cancer Research Studies
9.2.2 Agreements/Collaborations to Strengthen Cancer Research
9.2.3 Introduction of New Mice Model for Specific Cancers
9.2.4 Expansions to Support Cancer Research Facilities
9.3 Mice Model for Immunology and Inflammation Studies
9.4 Mice Model for Diabetes Studies
9.5 Mice Model for Cardiovascular Studies
9.6 Mice Model for Central Nervous System (CNS) Studies
9.7 Mice Model for Metabolism and Regulation Studies
9.8 Mice Model for Other Disease Studies

10 Mice Care Products Market, By Type
10.1 Introduction
10.2 Cages
10.3 Feed
10.4 Bedding
10.5 Others

11 Mice Model Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Revised Funding Plans By the Nih to Enhance Reproducibility of Results
11.2.1.2 Growing Biomedical Research in the U.S.
11.2.1.3 Monoclonal Antibody Production to Augment the Use of Mice Models
11.2.1.4 Continued and Responsible Use of Animals Ensured By Animal Care Organizations
11.2.1.5 Development of Biosimilars Boosting the Demand for Preclinical Services
11.2.1.6 Preclinical Activities By Cros and Pharmaceutical R&D
11.2.1.7 Partnerships Between Cros and Pharmaceutical Companies
11.2.2 Canada
11.2.2.1 Growing Stem Cell Research Activities in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Launch of Pro-Test Deutschland
11.3.1.2 Flourishing Biotechnology Industry
11.3.2 U.K.
11.3.2.1 Investors Demand Strong Statistics for Animal Studies in the U.K.
11.3.2.2 Increase in Cell Therapy Preclinical Research
11.3.3 France
11.3.3.1 Funding for Rare Disease Projects in France
11.3.4 Rest of Europe (RoE)
11.3.4.1 Improving Biomedical Industry in Russia
11.3.4.2 Growth in Biosimilars Market Calls for Increased Preclinical Activities
11.3.4.3 Focus on Rare Disease Research Projects
11.3.4.4 Events Conducted By Animal Care Associations to Promote the Ethical Use of Mice
11.3.4.5 Increase in Tailored Mice Models for Diseases Like Cancer
11.4 Asia-Pacific
11.4.1 China
11.4.1.1 International Alliances for R&D Activities in China
11.4.1.2 Growing Foray of Pharmaceutical and Mice Model Suppliers in China
11.4.1.3 Increasing Investments From Government and Private Sectors in China’s Life Sciences Sector
11.4.1.4 Initiatives to Reduce Longer Approval Times
11.4.1.5 Mandatory Animal Testing for All Pharmaceutical Drugs and Cosmetics in China
11.4.1.6 Intellectual Property (IP) Breaches, A Challenge for the Chinese Market
11.4.2 Japan
11.4.2.1 Growth in Biomedical and Medical Research in Japan
11.4.2.2 Research Into Regenerative Medicines
11.4.3 India
11.4.3.1 Growing Presence of Global Players
11.4.3.2 Development of Bioclusters to Boost India’s Biotechnology Industry
11.4.3.3 R&D Activities By Indian Pharmaceutical Companies to Boost Preclinical Research
11.4.3.4 Likely Shift of Outsourcing Preclinical Activities From India Towards European Nations
11.4.3.5 Limited Infrastructural Facilities in India, A Major Hindrance to the Mice Model Market
11.4.3.6 Weak Intellectual Property Environment in India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.4.4.1 Influx of International Players
11.4.4.2 Ongoing Biomedical Research Activities in Australia to Strengthen the Market
11.4.4.3 Growth in Translational and Biomedical Research in Singapore
11.4.4.4 Increase in Animal Research in Malaysia
11.4.4.5 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
11.5 Rest of World (RoW)
11.5.1.1 Pharmaceutical, Biotechnology, and Research Industries in Brazil to Bolster the Market
11.5.1.2 Favorable Business Environment for Pharmaceutical and Biotechnology Industries in Saudi Arabia and the Uae

12 Competitive Landscape
12.1 Overview
12.2 Market: Market Share Analysis (2014)
12.2.1 Charles River Laboratories International, Inc.
12.2.2 the Jackson Laboratory
12.2.3 Taconic Biosciences, Inc.
12.2.4 Harlan Laboratories, Inc. (Envigo)
12.3 Competitive Situation and Trends
12.3.1 Collaborations, Agreements, Strategic Alliances Partnerships, and Joint Ventures
12.3.2 Grants & Funds
12.3.3 Licensing
12.3.4 New Product Launches
12.3.5 Expansions
12.3.6 Patents
12.3.7 Acquisitions
12.3.8 Others

13 Company Profiles
13.1 Introduction
13.2 Charles River Laboratories International, Inc.
13.2.1 Business Overview
13.2.2 Products and Services Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 The Jackson Laboratory
13.3.1 Business Overview
13.3.2 Products and Services Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Taconic Biosciences, Inc.
13.4.1 Business Overview
13.4.2 Products and Services Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Envigo
13.5.1 Business Overview
13.5.2 Products and Services Offered
13.5.3 Recent Developments
13.5.4 MnM View
13.6 Covance, Inc.
13.6.1 Business Overview
13.6.2 Products and Services Offered
13.6.3 Recent Developments
13.7 Janvier Labs
13.7.1 Business Overview
13.7.2 Products and Services Offered
13.7.3 Recent Developments
13.8 Harbour Antibodies Bv
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.9 Transgenic, Inc.
13.9.1 Business Overview
13.9.2 Products and Services Offered
13.9.3 Recent Developments
13.10 Genoway SA
13.10.1 Business Overview
13.10.2 Products and Services Offered
13.10.3 Recent Developments
13.11 Sage Labs, Inc. (A Subsidiary of Horizon Discovery Group PLC)
13.11.1 Business Overview
13.11.2 Products and Services Offered
13.11.3 Recent Developments
13.12 Ingenious Targeting Laboratory
13.12.1 Business Overview
13.12.2 Products and Services Offered
13.12.3 Recent Developments

14 Appendix
14.1 Discussion Guide
14.2 Company Developments (2012-2015)
14.2.1 Charles River Laboratories International, Inc.
14.2.2 The Jackson Laboratory (JAX)
14.2.3 Taconic Biosciences Inc.
14.2.4 Envigo
14.2.5 Covance, Inc.
14.2.6 Transgenic, Inc.
14.2.7 Genoway SA
14.2.8 Sage Labs, Inc.
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports

List of Tables

Table 1 Ongoing Innovations in Mice Models are Propelling the Growth of Global Market
Table 2 Increased Usage of Rat Models is Limiting the Adoption of Mice Models in Research
Table 3 Increase in Monoclonal Antibody Production Using Mice Models has A Huge Potential for the Market
Table 4 Need for Improved Mice Models is A Major Market Challenge
Table 5 Market Size, By Type, 2013–2020 (USD Million)
Table 6 Inbred Market Size, By Country, 2013–2020 (USD Million)
Table 7 Outbred Market Size, By Country, 2013–2020 (USD Million)
Table 8 Genetically Engineered Market Size, By Country, 2013–2020 (USD Million)
Table 9 Hybrid/Congenic Market Size, By Country, 2013–2020 (USD Million)
Table 10 Conditioned/Surgically Modified Market Size, By Country, 2013–2020 (USD Million)
Table 11 Spontaneous Mutant Market Size, By Country, 2013–2020 (USD Million)
Table 12 Market Size, By Technology, 2013–2020 (USD Million)
Table 13 Microinjection Market Size, By Country, 2013–2020 (USD Million)
Table 14 Embryonic Stem Cell Injection Market Size, By Country, 2013–2020 (USD Million)
Table 15 Nuclear Transferase Market Size, By Country, 2013–2020 (USD Thousand)
Table 16 Other Mice Model Technologies Market Size, By Country, 2013–2020 (USD Thousand)
Table 17 Global Market, By Service, 2013–2020 (USD Million)
Table 18 Market Size for Breeding Services, By Country, 2013–2020 (USD Million)
Table 19 Market Size for Cryopreservation Services, By Country, 2013–2020 (USD Million)
Table 20 Market Size for Quarantine Services, By Country, 2013–2020 (USD Million)
Table 21 Market Size for Rederivation Services, By Country, 2013–2020 (USD Million)
Table 22 Market Size for Model In-Licensing Services, By Country, 2013–2020 (USD Million)
Table 23 Market Size for Genetic Testing Services, By Country, 2013–2020 (USD Million)
Table 24 Market Size for Other Services, By Country, 2013–2020 (USD Million)
Table 25 Global Market, By Disease, 2013–2020 (USD Million)
Table 26 Recent Cancer Research Studies Using Mice Models
Table 27 Oncology Mice Model Market Size, By Country, 2013–2020 (USD Million)
Table 28 Market for Immunology and Inflammation Studies, By Country, 2013–2020 (USD Million)
Table 29 Market for Diabetes Studies, By Country, 2013–2020 (USD Million)
Table 30 Market for Cardiovascular Studies, By Country, 2013–2020 (USD Million)
Table 31 Recent CNS Disorder-Related Research Studies Using Mice Models
Table 32 Market for Central Nervous System Studies, By Country, 2013–2020 (USD Million)
Table 33 Market for Metabolism and Regulation Studies, By Country, 2013–2020 (USD Million)
Table 34 Market for Other Disease Studies, By Country, 2013–2020 (USD Million)
Table 35 Global Mice Care Products Market Size, By Type, 2013–2020 (USD Million)
Table 36 Mice Care Products Market Size for Cages, By Region, 2013–2020 (USD Thousand)
Table 37 Mice Care Products Market Size for Feed, By Region, 2013–2020 (USD Thousand)
Table 38 Mice Care Products Market Size for Bedding, By Region, 2013–2020 (USD Thousand)
Table 39 Other Mice Care Products Market Size, By Region, 2013–2020 (USD Thousand)
Table 40 Market Size, By Region, 2013–2020 (USD Million)
Table 41 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 42 North America: Market Size, By Type, 2013–2020 (USD Million)
Table 43 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 44 North America: Market Size, By Service, 2013–2020 (USD Million)
Table 45 North America: Market Size, By Disease, 2013–2020 (USD Million)
Table 46 North America: Mice Care Products, By Type, 2013–2020 (USD Million)
Table 47 Nih Funding for Projects Related to Animal Models
Table 48 Associations Directly Related to the Animal Model Market
Table 49 Associations Indirectly Related to the Animal Model Market
Table 50 U.S.: Market Size, By Type, 2013–2020 (USD Million)
Table 51 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 52 U.S.: Market Size, By Service, 2013–2020 (USD Million)
Table 53 U.S.: Market Size, By Disease, 2013–2020 (USD Million)
Table 54 Canada: Market Size, By Type, 2013–2020 (USD Million)
Table 55 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 56 Canada: Market Size, By Service, 2013–2020 (USD Million)
Table 57 Canada: Market Size, By Disease, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By Country, 2013–2020 (USD Million)
Table 59 Europe: Market Size, By Type, 2013–2020 (USD Million)
Table 60 Europe: Market Size, By Technology, 2013–2020 (USD Million)
Table 61 Europe: Market Size, By Service, 2013–2020 (USD Million)
Table 62 Europe: Market Size, By Disease, 2013–2020 (USD Million)
Table 63 Europe: Mice Care Products, By Type, 2013–2020 (USD Thousand)
Table 64 Germany: Market Size, By Type, 2013–2020 (USD Million)
Table 65 Germany: Market Size, By Technology, 2013–2020 (USD Million)
Table 66 Germany: Market Size, By Service, 2013–2020 (USD Million)
Table 67 Germany: Market Size, By Disease, 2013–2020 (USD Million)
Table 68 U.K.: Market Size, By Type, 2013–2020 (USD Million)
Table 69 U.K.: Market Size, By Technology, 2013–2020 (USD Million)
Table 70 U.K.: Market Size, By Service, 2013–2020 (USD Million)
Table 71 U.K.: Market Size, By Disease, 2013–2020 (USD Million)
Table 72 France: Market Size, By Type, 2013–2020 (USD Million)
Table 73 France: Market Size, By Technology, 2013–2020 (USD Thousand)
Table 74 France: Market Size, By Service, 2013–2020 (USD Million)
Table 75 France: Market Size, By Disease, 2013–2020 (USD Million)
Table 76 Stages of Pharma 2020 Strategy
Table 77 European Animal Care Associations and Their Events
Table 78 RoE: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 79 RoE: Mice Model Market Size, By Technology, 2013–2020 (USD Million)
Table 80 RoE: Mice Model Market Size, By Service, 2013–2020 (USD Million)
Table 81 RoE: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 82 Asia-Pacific: Mice Model Market Size, By Country, 2013–2020 (USD Million)
Table 83 Asia-Pacific: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 84 Asia-Pacific: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 85 Asia-Pacific: Mice Model Market Size, By Service, 2013–2020 (USD Million)
Table 86 Asia-Pacific: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 87 Asia-Pacific: Mice Care Products, By Type, 2013–2020 (USD Thousand)
Table 88 China: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 89 China: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 90 China: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 91 China: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 92 Japan: Significant Partnerships
Table 93 Japan: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 94 Japan: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 95 Japan: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 96 Japan: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 97 Study Results Regarding R&D Expenditure of 25 Pharmaceutical Companies
Table 98 India: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 99 India: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 100 India: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 101 India: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 102 RoAPAC: Player Activity, 2013 to 2015
Table 103 Rest of Apac: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 104 Rest of Apac: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 105 Rest of Apac: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 106 Rest of Apac: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 107 RoW: Mice Model Market Size, By Type, 2013–2020 (USD Thousand)
Table 108 RoW: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 109 RoW: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 110 RoW: Mice Model Market Size, By Disease, 2013–2020 (USD Thousand)
Table 111 RoW: Mice Care Products, By Type, 2013–2020 (USD Thousand)
Table 112 Collaborations, Agreements, Strategic Alliances, Joint Ventures, and Partnerships (2012–2015)
Table 113 Grants & Funds, 2012–2015
Table 114 Licensing (2012–2015)
Table 115 New Product Launches (2012–2015)
Table 116 Key Players Focusing on Expansions (2012–2015)
Table 117 Patents (2012–2015)
Table 118 Acquisitions (2012–2015)
Table 119 Key Players Focusing on Other Strategies (2012–2015)

List of Figures

Figure 1 Global Mice Model Market: Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 North America Dominates the Global Mice Model Market
Figure 9 Cryopreservation Services Market to Grow at the Highest CAGR From 2015 to 2020
Figure 10 Asia-Pacific is Expected to Grow at the Highest Rate During the Forecast Period
Figure 11 Ongoing Innovations in Mice Models to Spur Market Growth During the Forecast Period
Figure 12 North America Dominated the Mice Care Products Market in 2015
Figure 13 Asia-Pacific Market to Witness the Highest Growth Rate During the Forecast Period
Figure 14 Microinjection Technology Commanded the Largest Share in 2015
Figure 15 Global Mice Model Market Segmentation
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Genetically Engineered Mice to Be the Fastest Growing Segment
Figure 18 Microinjection Technology Commanded the Largest Share of Mice Model Market in 2015
Figure 19 Mice Model Market, By Service
Figure 20 Breeding Services Accounted for the Largest Share of the Mice Model Market in 2015
Figure 21 Mice Model Market, By Disease
Figure 22 Oncology Mice Models to Dominate the Mice Model Market in 2015
Figure 23 Mice Care Products Market, By Type
Figure 24 Cages Accounted for the Largest Share of the Mice Care Products Market in 2015
Figure 25 Asia-Pacific to Grow at the Highest CAGR in the Mice Model Market During the Forecast Period
Figure 26 The U.S. Commanded the Largest Share in the Mice Model Market in North America in 2015
Figure 27 Germany Dominated the European Mice Model Market in 2015
Figure 28 Number of Cell Therapy Preclinical Studies Listed in the Preclinical Research Database in the U.K., 2013-2015
Figure 29 China: the Fastest Growing Country in the Asia-Pacific Mice Model Market
Figure 30 China Pharma Partnering Activity By Stage – 2009-2014
Figure 31 Oncology Mice Models to Dominate the RoW Mice Models Market, By Diseases
Figure 32 Major Players Focused on Inorganic Growth Strategies
Figure 33 Mice Model Market Share, By Key Player, 2014
Figure 34 Battle for Market Share: Major Collaborations, Agreements, Strategic Alliances, Joint Ventures, and Partnerships Formed the Key Strategy (2012-2015)
Figure 35 Key Players Focusing on Collaborations, Agreements, Strategic Alliances, Joint Ventures, and Partnerships (2012–2015)
Figure 36 Key Players Focusing on Grants & Funds (2012-2015)
Figure 37 Key Players Focusing on Licensing (2012-2015)
Figure 38 Key Players Focusing on New Product Launches (2012-2015)
Figure 39 Key Players Focusing on Expansions (2012-2015)
Figure 40 Key Players Focusing on Patents (2012-2015)
Figure 41 Key Players Focusing on Acquisitions (2012-2015)
Figure 42 Key Players Focusing on Other Strategies (2012-2015)
Figure 43 Business Focus of Top Market Players
Figure 44 Charles River Laboratories International, Inc.: Company Snapshot
Figure 45 The Jackson Laboratory: Company Snapshot
Figure 46 Covance, Inc.: Company Snapshot
Figure 47 Genoway SA: Company Snapshot